Inicio › Cáncer de vías biliares › Texas › Houston
Ensayos clínicos de Cáncer de vías biliares en Houston, TX
18 estudios para Cáncer de vías biliares buscan participantes en centros de Houston y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
ReclutandoFase 2
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
ReclutandoFase 2
- Research Site, Houston
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
ReclutandoFase 3
- Research Site, Houston
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
ReclutandoFase 1/2
- MD Anderson Cancer Center, GI Medical Oncology Dept, Houston
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
ReclutandoFase 1/2
- University of Texas MD Anderson Cancer Center ( Site 0316), Houston
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
ReclutandoFase 2
- Research Site, Houston
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
ReclutandoFase 1
- Oncology Consultants, Houston
CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers
ReclutandoFase 1/2
- MD Anderson Cancer Center, Houston
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
ReclutandoFase 1/2
- Avenzo Therapeutics Recruiting Site, Houston
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
ReclutandoFase 1
- MD Anderson, Houston
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
ReclutandoFase 3
- Research Site, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- The University of Texas, MD Anderson Cancer Center, Houston
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
ReclutandoFase 2
- University of Texas MD Anderson Cancer Center, Houston
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
ReclutandoFase 1
- The University of Texas MD Anderson Cancer Center, Houston
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
ReclutandoFase 1
- The University of Texas MD Anderson Cancer Center, Houston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
ReclutandoFase 1/2
- MD Anderson Cancer Center, Houston
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
ReclutandoFase 2
- Houston Methodist Hospital Cancer Center, Houston
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
ReclutandoFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Ensayos de Cáncer de vías biliares en otras ciudades
- Los Angeles, CA11 estudios
- Boston, MA11 estudios
- New York City, NY10 estudios
- Nashville, TN9 estudios
- Baltimore, MD8 estudios
- San Antonio, TX8 estudios
- Washington, DC7 estudios
- Pittsburgh, PA7 estudios
- Arlington, VA7 estudios
- Madison, WI6 estudios
- Columbus, OH6 estudios
- Cleveland, OH6 estudios
Otros estudios en Houston
- Cáncer de pulmón de células no pequeñas145 estudios
- Cáncer de seno126 estudios
- Cáncer (todos los tipos)121 estudios
- Cáncer metastásico104 estudios
- Cáncer del colon y del recto102 estudios
- Cáncer de ovario89 estudios
- Leucemia mielógena aguda85 estudios
- Cáncer de pulmón78 estudios
- Cáncer de próstata76 estudios
- Cáncer de endometrio68 estudios
- Cáncer de páncreas61 estudios
- Melanoma59 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.